Limit search to available items
12 results found. Sorted by relevance | date | title .
Book Cover
E-book

Title Guide to Diagnostic Tests / Diana Nicoll, Chuanyi Mark Lu, Stephen J McPhee
Edition 7th ed
Published New York, N.Y. : McGraw-Hill Education LLC., c2017
Online access available from:
Access Medicine    View Resource Record  

Copies

Description 1 online resource : ill., figs., tables
Series McGraw-Hill's AccessMedicine
McGraw-Hill's AccessMedicine.
Contents INTRODUCTION -- BENEFITS, COSTS & RISKS -- PERFORMANCE OF DIAGNOSTIC TESTS -- TEST CHARACTERISTICS -- USE OF TESTS IN DIAGNOSIS & MANAGEMENT -- ODDS-LIKELIHOOD RATIOS -- REFERENCES -- INTRODUCTION -- 1. OBTAINING & HANDLING SPECIMENS -- 2. COMMONLY USED POINT-OF-CARE TESTS -- 3. PROVIDER-PERFORMED MICROSCOPY PROCEDURES -- 4. POINT-OF-CARE ULTRASOUND EXAMINATION -- REFERENCES -- HOW TO USE THIS SECTION -- ABO TYPING -- ACETAMINOPHEN -- ACETOACETATE -- ACETYLCHOLINE RECEPTOR ANTIBODIES -- ACTIVATED CLOTTING TIME -- ADRENOCORTICOTROPIC HORMONE -- ALANINE AMINOTRANSFERASE -- ALBUMIN, SERUM OR PLASMA -- ALBUMIN, URINE -- ALDOSTERONE, SERUM -- ALDOSTERONE, URINE -- ALKALINE PHOSPHATASE -- AMMONIA -- AMYLASE -- ANGIOTENSIN-CONVERTING ENZYME -- ANTIBODY SCREEN -- ANTIDIURETIC HORMONE -- ANTIGLOBULIN TEST, DIRECT -- ANTIGLOBULIN TEST, INDIRECT -- ANTITHROMBIN -- α1-ANTITRYPSIN -- ARTERIAL BLOOD GASES -- ASPARTATE AMINOTRANSFERASE -- B CELL IMMUNOGLOBULIN GENE REARRANGEMENT -- BCR/ABL, T(9;22) TRANSLOCATION BY RT-PCR -- BCR/ABL MUTATION ANALYSIS -- BETA-D-GLUCAN, SERUM -- BETA-hCG -- BILIRUBIN -- BLOOD UREA NITROGEN -- B-TYPE NATRIURETIC PEPTIDE -- BRCA1 AND BRCA2 GENOTYPING -- BRUCELLA ANTIBODY -- C-PEPTIDE -- C-REACTIVE PROTEIN, HIGH SENSITIVITY -- C1 ESTERASE INHIBITOR (C1-INH) -- CALCITONIN -- CALCIUM, SERUM OR PLASMA -- CALCIUM, IONIZED -- CALCIUM, URINE, 24-HOUR -- CALRETICULIN (CALR) MUTATION ANALYSIS -- CARBON DIOXIDE, PARTIAL PRESSURE -- CARBON DIOXIDE (TOTAL BICARBONATE) -- CARBOXYHEMOGLOBIN (COHb) -- CARCINOEMBRYONIC ANTIGEN (CEA) -- CD4 CELL COUNT -- CELIAC DISEASE (GLUTEN ENTEROPATHY), SEROLOGIC TESTING -- CENTROMERE ANTIBODIES (ACA) -- CERULOPLASMIN, SERUM OR PLASMA -- CHLORIDE -- CHOLESTEROL, SERUM OR PLASMA -- CLOSTRIDIUM DIFFICILE TOXINS -- COCCIDIOIDES ANTIBODIES -- COLD AGGLUTININS, SERUM -- COMPLEMENT C3 -- COMPLEMENT C4 -- COMPLEMENT, TOTAL (CH50) -- COMPLETE BLOOD CELL COUNT -- CORTISOL, SERUM OR PLASMA -- CORTISOL (URINARY FREE) -- COSYNTROPIN/CORTROSYN STIMULATION TEST -- CREATINE KINASE, TOTAL -- CREATINE KINASE, MB -- CREATININE, SERUM OR PLASMA -- CREATININE CLEARANCE -- CRYOGLOBULINS, QUALITATIVE, SERUM -- CRYPTOCOCCAL ANTIGEN, SERUM AND CSF -- C-TELOPEPTIDE, BETA-CROSS-LINKED (CTX-BETA) -- CYCLIC CITRULLINATED PROTEIN ANTIBODY (CCP ANTIBODY) -- CYSTATIN C -- CYTOMEGALOVIRUS ANTIBODIES (IgG AND IgM), SERUM -- D-DIMER -- DEHYDROEPIANDROSTERONE SULFATE (DHEA-S) -- DEXAMETHASONE SUPPRESSION TEST (LOW DOSE, OVERNIGHT) -- DEXAMETHASONE SUPPRESSION TEST (HIGH DOSE, OVERNIGHT) -- DOUBLE-STRANDED DNA ANTIBODY -- DRUG ABUSE SCREEN, URINE (URINE DRUG TESTING) -- EPSTEIN-BARR VIRUS ANTIBODIES (EBV ANTIBODIES) -- ERYTHROCYTE SEDIMENTATION RATE -- ERYTHROPOIETIN (EPO) -- ESTRADIOL -- ETHANOL -- FACTOR ASSAYS (COAGULATION FACTOR ASSAYS) -- FACTOR II (PROTHROMBIN) MUTATION -- FACTOR V LEIDEN MUTATION -- FACTOR VIII ASSAY -- FECAL FAT, QUANTIFICATION -- FECAL OCCULT BLOOD TESTS -- FERRITIN -- α-FETOPROTEIN (AFP) -- FIBRINOGEN (FUNCTIONAL) -- FLUORESCENT TREPONEMAL ANTIBODY-ABSORBED -- FOLIC ACID (FOLATE) -- FOLLICLE-STIMULATING HORMONE -- FRUCTOSAMINE -- GAMMA-GLUTAMYL TRANSPEPTIDASE -- GASTRIN -- GLOMERULAR FILTRATION RATE, ESTIMATED (EGFR) -- GLUCAGON -- GLUCOSE
GLUCOSE TOLERANCE TEST -- G6PD (GLUCOSE-6-PHOSPHATE DEHYDROGENASE) -- GROWTH HORMONE -- HAPTOGLOBIN -- HELICOBACTER PYLORI TESTS -- HEMATOCRIT -- HEMOGLOBIN A1C, BLOOD -- HEMOGLOBIN A2 -- HEMOGLOBIN ELECTROPHORESIS AND EVALUATION -- HEMOGLOBIN, FETAL -- HEMOGLOBIN, TOTAL -- HEPARIN ANTI-XA ASSAY, CHROMOGENIC -- HEPARIN-INDUCED THROMBOCYTOPENIA (HIT) ANTIBODIES -- HEPATITIS A VIRUS ANTIBODY -- HEPATITIS B SURFACE ANTIGEN -- HEPATITIS B SURFACE ANTIBODY -- HEPATITIS B CORE ANTIBODY -- HEPATITIS B E ANTIGEN -- HEPATITIS B VIRUS DNA, QUANTITATIVE -- HEPATITIS C VIRUS ANTIBODY -- HEPATITIS C VIRUS GENOTYPING -- HEPATITIS C VIRUS RNA (HCV-RNA), QUANTITATIVE -- HEPATITIS DELTA ANTIBODY -- HEPATITIS E VIRUS ANTIBODY -- HETEROPHILE ANTIBODY -- HISTOPLASMA CAPSULATUM ANTIGEN -- HISTOPLASMA CAPSULATUM ANTIBODIES BY IMMUNODIFFUSION -- HISTOPLASMA CAPSULATUM ANTIBODIES BY CF -- HIV ANTIBODY -- HIV RNA, QUANTITATIVE -- HIV RESISTANCE TESTING -- HLA TYPING -- HLA-B27 TYPING -- HLA-B51 TYPING -- HOMOCYSTEINE -- 5-HYDROXYINDOLEACETIC ACID -- IGG INDEX -- INCREASE IN IGG4: -- IMMUNOFIXATION ELECTROPHORESIS -- IMMUNOGLOBULINS -- INHIBITOR SCREEN (1:1 MIX) -- INSULIN ANTIBODY -- INSULIN, IMMUNOREACTIVE -- INSULIN-LIKE GROWTH FACTOR-1 -- INTRINSIC FACTOR BLOCKING ANTIBODY -- IODINE -- IRON -- IRON-BINDING CAPACITY -- ISLET CELL ANTIBODIES -- JAK2 (V617F) MUTATION -- KAPPA AND LAMBDA FREE LIGHT CHAINS WITH RATIO -- LACTATE DEHYDROGENASE -- LACTATE -- LEAD -- LEGIONELLA ANTIBODY -- LEUKEMIA/LYMPHOMA PHENOTYPING BY FLOW CYTOMETRY -- LIPASE -- LIPOPROTEIN(A) -- LIPOPROTEIN ASSOCIATED PHOSPHOLIPASE A2 (LP-PLA2) -- LUTEINIZING HORMONE -- LYME DISEASE ANTIBODY -- MAGNESIUM -- MEAN CORPUSCULAR HEMOGLOBIN -- MEAN CORPUSCULAR HEMOGLOBIN CONCENTRATION -- MEAN CORPUSCULAR VOLUME -- METANEPHRINES, FREE (UNCONJUGATED), PLASMA -- METANEPHRINES, FRACTIONATED, URINE -- METHANOL -- METHEMOGLOBIN -- MTHFR MUTATION -- METHYLMALONIC ACID -- β2-MICROGLOBULIN -- MITOCHONDRIAL ANTIBODIES -- NEUTROPHIL CYTOPLASMIC ANTIBODIES -- N-TELOPEPTIDE, CROSS-LINKED -- NUCLEAR ANTIBODY -- OLIGOCLONAL BANDS -- OSMOLALITY, SERUM -- OSMOLALITY, URINE -- OSTEOCALCIN -- OXYGEN, PARTIAL PRESSURE -- PANCREATIC ELASTASE -- PARATHYROID HORMONE -- PARATHYROID HORMONE-RELATED PROTEIN -- PARTIAL THROMBOPLASTIN TIME -- pH -- PHOSPHORUS -- PLATELET ANTIBODIES -- PLATELET COUNT -- PLATELET FUNCTION ASSAY -- PORPHOBILINOGEN -- POTASSIUM -- PROCALCITONIN -- PROCOLLAGEN TYPE I N-TERMINAL PROPEPTIDE (PINP) -- PROLACTIN -- PROSTATE-SPECIFIC ANTIGEN -- PROTEIN C -- PROTEIN ELECTROPHORESIS -- PROTEIN S -- PROTEIN, TOTAL -- PROTHROMBIN TIME -- Q FEVER ANTIBODY -- QUANTIFERON-TB (INTERFERON-GAMMA RELEASING ASSAY) -- RAPID PLASMA REAGIN -- RED BLOOD CELL COUNT -- RENIN ACTIVITY -- RETICULOCYTE COUNT -- Rh(D) TYPING -- RHEUMATOID FACTOR -- RIBONUCLEOPROTEIN ANTIBODY -- RIBOSOMAL DNA (16S rDNA) SEQUENCING -- RUBELLA ANTIBODY -- RUSSELL VIPER VENOM TIME (dRVVT) -- SALICYLATE -- SCLERODERMA-ASSOCIATED ANTIBODY -- SEMEN ANALYSIS -- SMITH (ANTI-Sm) ANTIBODY -- SMOOTH MUSCLE ANTIBODIES -- SODIUM -- SOMATOSTATIN -- SS-A/Ro ANTIBODY -- SS-B/La ANTIBODY -- SYPHILIS, SEROLOGIC TESTING -- T-CELL RECEPTOR GENE REARRANGEMENT -- TESTOSTERONE
THROMBIN TIME -- THYROGLOBULIN -- THYROGLOBULIN ANTIBODY -- THYROID PEROXIDASE ANTIBODY -- THYROID-STIMULATING HORMONE -- THYROID STIMULATING IMMUNOGLOBULIN -- THYROXINE, TOTAL -- THYROXINE, FREE -- TOXOPLASMA ANTIBODY -- TRANSFERRIN -- TRANSFERRIN RECEPTOR, SOLUBLE -- TREPONEMA PALLIDUM ANTIBODY -- TRIGLYCERIDES -- TRIIODOTHYRONINE -- TROPONIN-I, CARDIAC -- TULAREMIA AGGLUTININS -- TYPE AND CROSSMATCH -- TYPE AND SCREEN -- URIC ACID -- VANILLYLMANDELIC ACID -- VDRL TEST, SERUM -- VITAMIN B12 -- VITAMIN D, 25-HYDROXY -- VITAMIN D, 1,25-DIHYDROXY -- von WILLEBRAND FACTOR -- WHITE BLOOD CELL COUNT AND DIFFERENTIAL -- ZINC PROTOPORPHYRIN (ZPP) -- UNDERLYING ASSUMPTIONS -- INDICATIONS FOR DRUG MONITORING -- SITUATIONS IN WHICH DRUG MONITORING MAY NOT BE USEFUL -- OTHER INFORMATION REQUIRED FOR EFFECTIVE DRUG MONITORING -- PHARMACOKINETIC PARAMETERS -- GENETIC INFLUENCES ON THERAPEUTIC DRUG RESPONSE -- CLINICAL USE OF PHARMACOGENETIC TESTING -- REFERENCES -- HOW TO USE THIS SECTION -- BRAIN ABSCESS -- ENCEPHALITIS -- ASEPTIC MENINGITIS -- BACTERIAL MENINGITIS -- FUNGAL MENINGITIS -- SPIROCHETAL MENINGITIS/NEUROLOGIC DISEASES -- PARASITIC MENINGOENCEPHALITIS -- TUBERCULOUS MENINGITIS -- CONJUNCTIVITIS -- KERATITIS -- ENDOPHTHALMITIS -- OTITIS MEDIA -- OTITIS EXTERNA -- SINUSITIS -- PHARYNGITIS -- LARYNGITIS -- LARYNGOTRACHEOBRONCHITIS -- EPIGLOTTITIS -- COMMUNITY-ACQUIRED PNEUMONIA -- ANAEROBIC PNEUMONIA -- HOSPITAL-ACQUIRED PNEUMONIA -- PNEUMONIA IN IMMUNOCOMPROMISED HOST -- MYCOBACTERIAL PNEUMONIA -- EMPYEMA -- PERICARDITIS -- TUBERCULOUS PERICARDITIS -- INFECTIOUS MYOCARDITIS -- INFECTIVE ENDOCARDITIS -- INFECTIOUS THROMBOPHLEBITIS -- GASTRITIS -- INFECTIOUS ESOPHAGITIS -- INFECTIOUS COLITIS/DYSENTERY -- ANTIBIOTIC-ASSOCIATED COLITIS -- DIARRHEA IN HIV -- PERITONITIS -- TUBERCULOUS PERITONITIS/ENTEROCOLITIS -- DIVERTICULITIS -- LIVER ABSCESS -- CHOLANGITIS/CHOLECYSTITIS -- URINARY TRACT INFECTION -- PROSTATITIS -- PYELONEPHRITIS -- PERINEPHRIC ABSCESS -- URETHRITIS -- EPIDIDYMITIS/ORCHITIS -- VAGINITIS/VAGINOSIS -- CERVICITIS -- SALPINGITIS -- CHORIOAMNIONITIS/ENDOMETRITIS -- OSTEOMYELITIS -- BACTERIAL/SEPTIC ARTHRITIS -- GAS GANGRENE -- IMPETIGO -- CELLULITIS -- BACTEREMIA OF UNKNOWN SOURCE -- ACINETOBACTER -- AVIAN INFLUENZA A/H5N1, AVIAN INFLUENZA A/H7N9, AND NOVEL H1N1 INFLUENZA A -- CARBAPENEM-RESISTANT ENTEROBACTERIACEAE (CRE) -- CHIKUNGUNYA VIRUS -- CLOSTRIDIUM DIFFICILE -- CRYPTOCOCCUS GATTII -- DENGUE VIRUS -- EBOLA VIRUS -- ESCHERICHIA COLI, DIARRHEAGENIC -- E. COLI, DIFFUSELY ADHERENT (DAEC) -- E. COLI, ENTEROAGGREGATIVE (EAEC) -- E. COLI, ENTEROHEMORRHAGIC/SHIGA-TOXIN-PRODUCING E. COLI (EHEC/STEC) -- E. COLI, ENTEROINVASIVE (EIEC) -- E. COLI, ENTEROPATHOGENIC (EPEC) -- E. COLI, ENTEROTOXIGENIC (ETEC) -- HUMAN GRANULOCYTOTROPIC ANAPLASMOSIS (HGA) -- HUMAN METAPNEUMOVIRUS (huMPV) -- HUMAN MONKEYPOX VIRUS -- HUMAN MONOCYTIC EHRLICHIOSIS (HME) -- LYME DISEASE -- METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS (MRSA) -- MIDDLE EAST RESPIRATORY SYNDROME CORONAVIRUS (MERS-CoV) -- MUMPS -- SEVERE ACUTE RESPIRATORY SYNDROME-CORONAVIRUS A (SARS-CoA) -- STREPTOCOCCUS PNEUMONIAE, RESISTANT -- TRANSMISSIBLE SPONGIFORM ENCEPHALOPATHY (TSE) -- WEST NILE VIRUS (WNV) -- VANCOMYCIN-RESISTANT ENTEROCOCCUS (VRE) -- ZIKA VIRUS -- HOW TO USE THIS SECTION -- RISKS OF IODINATED CT INTRAVENOUS CONTRAST AGENTS -- RISKS OF GADOLINIUM-BASED MRI INTRAVENOUS CONTRAST AGENTS
I. BASIC ELECTROCARDIOGRAPHY -- STEP ONE: DIAGNOSIS OF THE CARDIAC RHYTHM -- MORPHOLOGY ALGORITHMS FOR IDENTIFYING VT -- STEP TWO: MORPHOLOGIC DIAGNOSIS OF THE CARDIAC WAVEFORMS -- II. BASIC ECHOCARDIOGRAPHY -- REFERENCES -- HOW TO USE THIS SECTION -- ACID-BASE DISTURBANCE: LABORATORY CHARACTERISTICS OF PRIMARY OR SINGLE ACID-BASE DISTURBANCE -- ANEMIA: DIAGNOSIS OF COMMON ANEMIAS BASED ON RED CELL INDICES -- ANEMIA: LABORATORY EVALUATION OF MICROCYTIC, HYPOCHROMIC ANEMIAS -- ANTICOAGULANTS: MECHANISM OF ACTION, CLINICAL INDICATIONS, AND LABORATORY MONITORING -- ARTHRITIS: EXAMINATION AND CLASSIFICATION OF SYNOVIAL (JOINT) FLUID -- ASCITES: ASCITIC FLUID PROFILES IN VARIOUS DISEASE STATES -- AUTOANTIBODIES: FREQUENCY (%) OF AUTOANTIBODIES IN RHEUMATIC DISEASES -- BLEEDING DISORDERS: LABORATORY EVALUATION -- CEREBROSPINAL FLUID (CSF): CSF PROFILES IN CENTRAL NERVOUS SYSTEM DISEASES -- CIRRHOSIS: CHILD-PUGH STAGES AND MODEL FOR END-STAGE LIVER DISEASE (MELD) SCORING SYSTEM -- GENETIC DISEASES: MOLECULAR DIAGNOSTIC TESTING -- HEPATITIS B VIRUS INFECTION: COMMON SEROLOGIC TEST PATTERNS AND THEIR INTERPRETATION -- LEUKEMIAS AND LYMPHOMAS: CLASSIFICATION AND IMMUNOPHENOTYPING -- OSMOL GAP: CALCULATION AND APPLICATION IN CLINICAL TOXICOLOGY -- RANSON CRITERIA FOR ASSESSING SEVERITY OF ACUTE PANCREATITIS -- PLEURAL EFFUSION: PLEURAL FLUID PROFILES IN VARIOUS DISEASE STATES -- PRENATAL DIAGNOSTIC METHODS: AMNIOCENTESIS, CHORIONIC VILLUS SAMPLING, AND CORDOCENTESIS -- PULMONARY FUNCTION TESTS: INTERPRETATION IN OBSTRUCTIVE AND RESTRICTIVE PULMONARY DISEASES -- RENAL FAILURE: CLASSIFICATION AND DIFFERENTIAL DIAGNOSIS -- RENAL TUBULAR ACIDOSIS (RTA): LABORATORY DIAGNOSIS -- SYPHILIS: CLINICAL AND LABORATORY DIAGNOSIS IN UNTREATED PATIENTS -- THALASSEMIA SYNDROMES: GENETICS AND LABORATORY CHARACTERISTICS -- TRANSFUSION: SUMMARY CHART OF BLOOD COMPONENT THERAPY -- VALVULAR HEART DISEASE: DIAGNOSTIC EVALUATION -- HOW TO USE THIS SECTION -- ACID-BASE DISTURBANCES: DIAGNOSTIC APPROACH -- ADRENAL MASS: DIAGNOSTIC EVALUATION -- ADRENOCORTICAL INSUFFICIENCY (HYPOCORTISOLISM): LABORATORY EVALUATION OF SUSPECTED ADRENOCORTICAL INSUFFICIENCY (HYPOCORTISOLISM) -- AMENORRHEA OR OLIGOMENORRHEA: DIAGNOSTIC LABORATORY EVALUATION FOR AMENORRHEA OR OLIGOMENORRHEA -- ANEMIA: GENERAL CONSIDERATIONS AND INITIAL EVALUATION -- ASCITES: DIAGNOSTIC EVALUATION -- BLEEDING DISORDERS, INHERITED: EVALUATION OF SUSPECTED INHERITED BLEEDING DISORDERS -- CUSHING SYNDROME (HYPERCORTISOLISM): DIAGNOSTIC EVALUATION OF SUSPECTED CUSHING SYNDROME (HYPERCORTISOLISM) -- GOITER: DIAGNOSTIC EVALUATION AND MANAGEMENT STRATEGY -- HEMOCHROMATOSIS: DIAGNOSTIC EVALUATION OF SUSPECTED HEMOCHROMATOSIS -- HCV INFECTION: DIAGNOSTIC STRATEGY FOR PATIENTS WITH SUSPECTED HCV INFECTION -- HIV INFECTION: DIAGNOSTIC STRATEGY FOR PATIENTS WITH SUSPECTED HIV INFECTION -- HIRSUTISM: EVALUATION OF HIRSUTISM IN FEMALES -- HYPERALDOSTERONISM: LABORATORY EVALUATION OF SUSPECTED HYPERALDOSTERONISM -- HYPERCALCEMIA: DIAGNOSTIC APPROACH TO HYPERCALCEMIA -- HYPERTHYROIDISM: LABORATORY EVALUATION -- HYPOCALCEMIA: DIAGNOSTIC APPROACH TO HYPOCALCEMIA -- HYPONATREMIA: EVALUATION OF HYPONATREMIA
HYPOTHYROIDISM: DIAGNOSTIC APPROACH -- INFERTILITY, FEMALE: EVALUATION OF FEMALE INFERTILITY -- INFERTILITY, MALE: EVALUATION OF MALE FACTOR INFERTILITY -- JAUNDICE: GENERAL CONSIDERATIONS AND INITIAL LABORATORY EVALUATION -- LYMPHOCYTOSIS: GENERAL APPROACH TO ESTABLISHED LYMPHOCYTOSIS -- MONOARTHRITIS, ACUTE: EVALUATION OF ACUTE MONOARTHRITIS -- PHEOCHROMOCYTOMA: EVALUATION AND LOCALIZATION OF A POSSIBLE PHEOCHROMOCYTOMA -- POLYCYTHEMIA: DIAGNOSTIC EVALUATION -- PORPHYRIA, ACUTE: LABORATORY EVALUATION OF SUSPECTED ACUTE NEUROVISCERAL OR NEUROCUTANEOUS PORPHYRIA -- ISOLATED PROLONGATION OF PTT: LABORATORY EVALUATION -- PULMONARY EMBOLISM: DIAGNOSTIC STRATEGY FOR PATIENTS WITH SUSPECTED PULMONARY EMBOLISM -- SLEEP DISTURBANCE: DIAGNOSTIC EVALUATION -- SYPHILIS SEROLOGIC TESTING: TWO COMMONLY USED APPROACHES TO THE SEROLOGICAL DIAGNOSIS OF SYPHILIS -- THROMBOCYTOPENIA, ACQUIRED: DIAGNOSTIC APPROACH TO ACQUIRED THROMBOCYTOPENIA -- THROMBOCYTOSIS: DIAGNOSTIC EVALUATION OF SUSTAINED THROMBOCYTOSIS -- THROMBOSIS, VENOUS: EVALUATION FOR POSSIBLE HYPERCOAGULABILITY (THROMBOPHILIA) CAUSING VENOUS THROMBOSIS -- THYROID NODULE: DIAGNOSTIC EVALUATION -- TRANSFUSION: BLOOD DONATION AND PREPARATION OF BLOOD COMPONENTS -- HOW TO USE THIS SECTION -- ACID-BASE NOMOGRAM -- COAGULATION CASCADE -- COMPLEMENT SYSTEM -- DERMATOME CHART -- HEPATITIS A SEROLOGIC CHANGES -- HEPATITIS B SEROLOGIC CHANGES -- HEPATITIS C SEROLOGY AND VIRAL LOAD -- PARATHYROID HORMONE AND CALCIUM NOMOGRAM -- PULMONARY FUNCTION TESTS: SPIROMETRY -- STEROIDOGENESIS PATHWAY
Bibliography Includes bibliographical references and indexes
Notes Also issued in Online and PDF version
Description based on cover image and table of contents, viewed on Mar. 06, 2017
Subject Diagnosis, Laboratory -- Handbooks, manuals, etc.
Diagnostic imaging -- Handbooks, manuals, etc.
Clinical Laboratory Techniques
Diagnosis, Differential.
Diagnostic Imaging
Diagnostic Tests, Routine
Diagnostic Tests, Routine.
Reading List HMP703 recommended text 2024
HMP709 recommended text 2024
Form Electronic book
Author Nicoll, Diana, ed.
Lu, Chuanyi Mark, ed.
McPhee, Stephen J., ed.
ISBN 9781259640896 (print-ISBN)
1259640892 (print-ISBN)
9781259640902 (e-ISBN)
1259640906 (e-ISBN)
Other Titles Guide to Diagnostic Tests, Seventh edition